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PaenibacillusBacillus and related genera in the Bacillales within the Firmicutes harbor a variety of secondary metabolite gene
clusters encoding polyketide synthases and non-ribosomal peptide synthetases responsible for remarkable
diverse number of polyketides (PKs) and lipopeptides (LPs). These compounds may be utilized for medical and
agricultural applications. Here,we summarize the knowledge on structural diversity and underlying gene clusters
of LPs and PKs in the Bacillales. Moreover, we evaluate by using published prediction tools the potentialmetabolic
capacity of these bacteria to produce type I PKs or LPs. The huge sequence repository of bacterial genomes and
metagenomes provides the basis for such genome-mining to reveal the potential for novel structurally diverse
secondary metabolites. The otherwise cumbersome task to isolate often unstable PKs and deduce their structure
can be streamlined. Using web based prediction tools, we identiﬁed here several novel clusters of PKs and LPs
from genomes deposited in the database. Our analysis suggests that a substantial fraction of predicted LPs and
type I PKs are uncharacterized, and their functions remain to be studied. Known and predicted LPs and PKs
occurred in the majority of the plant associated genera, predominantly in Bacillus and Paenibacillus. Surprisingly,
many genera fromother environments contain no or fewof such compounds indicating the role of these secondary
metabolites in plant-associated niches.
© 2015 Aleti et al. Published by Elsevier B.V. on behalf of the Research Network of Computational and Structural
Biotechnology. This is an open access article under the CC BY license
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Bacteria are known to produce structurally diverse secondary
metabolites including aminoglycosides, polyketides (PKs) and
several small proteinaceous and peptidal structures such as bacterio-
cins, oligopeptides and lipopeptides (LPs) [1–3]. A substantial
number of these metabolites have been described for their bacteri-
cidal, immune suppression and tumor suppression properties and
represent potentially valuable agents in medical and veterinary
medical applications, but especially PKs and LPs play also essential
roles for applications in agriculture. They are vital for bacterial
activities in suppressing disease pressure in plants by antimicrobial
activities and activating plant defense and are important for bioﬁlm
formation and root colonization of crop plants [4–8]. LPs and PKs
encompass a variety of cyclic, linear and branched structures and
are generated by complex enzymes known as non-ribosomal peptide
synthetases (NRPS) and polyketide synthases (PKS), respectively [9,
10]. NRPS and type I PKS share to a large extent similar modular
architecture and are largely organized into modules containing mul-
tiple domains, allowing the repetitive incorporation of building
blocks into larger resulting compounds [11]. However, for the bio-
synthesis of smaller compounds (e.g. some siderophores), non-
modular NRPS have been reported [12]. Often NRPS and type I
PKS enzymes work using a co-linearity code, so that the recruitment
of amino acids (for NRPS) and carboxylic acids (for PKS) for the
biosynthesis and ﬁnal structure assembly is the same as the order
of catalytic domains in the genome [13,14]. This feature and
insight into the architecture of modules and domains of NRPS and
PKS often facilitate prediction of compound structures based on
genomic sequences [15,16]. Nevertheless, variations from this
conventional organization have been described and include for in-
stance module iteration and skipping in several biosynthetic
processes [17].
In this review, we will focus on Bacillales, an order belonging to
the phylum Firmicutes, as genera within this order represent a rich
source for diverse secondary metabolite gene clusters. Based on a re-
cent whole genome mining study, 31% of the Firmicutes are estimat-
ed to harbor NRPS and PKS secondary metabolite gene clusters. 70%
of these encode NRPS and 30% hybrid NRPS/PKS or PKS [18]. The
total percentage of Firmicutes producing secondary metabolites is
certainly higher, also because genes responsible for many common
secondary metabolite classes (e.g. many oligosaccharides) are not
detected by widely used prediction tools such as antiSMASH[19,
20]. The distribution of NRPS and PKS gene clusters within different
orders of the Firmicutes is not uniform and Bacillus and Paenibacillus
from the order Bacillales dominate this secondary metabolite gene
clusters count. These two genera in particular are well noted for
their capability to produce structurally diverse LPs and PKs [4,7],
but the genome information from most other Bacillales members re-
mains largely untapped.
Despite the fact that next generation sequencing technology has
contributed to the ample availability of the whole genome sequence
data and a number of analysis tools for metabolite prediction exist
[19–23], yet little is accomplished to explore the sequence wealth
to identify novel LPs and PKs in these genomes and to predict
uncharacterized secondary metabolites. We brieﬂy review current
knowledge on well characterized LPs and PKs from the Bacillales
and show which novel compounds can be anticipated based on
published Bacillales genome data using genome mining study and
secondary metabolite prediction tools. The questions addressed
here are to review the structural and functional information and
the underlying gene clusters of known type I PKs and LPs produced
by Bacillales and to elucidate by genome mining potential products
of uncharacterized gene clusters and the potential of producing
yet unidentiﬁed secondary metabolites of these types in distinct
taxonomic groups of the Bacillales.1.1. Bacillus and Paenibacillus polyketides
Polyketides are generated from simpler building units by repeated
decarboxylation and condensation cycles on PKS enzymes [24].
The PKS machinery comprises three core domains: the acyl transferase
(AT), the acyl carrier protein (ACP) and the ketosynthase (KS). The
AT domain is responsible for activation and transfer of a simpler
building unit (malonyl coenzyme A) to the ACP domain. The KS domain
catalyzes decarboxylation and condensation reaction between the two
ACP linked malonates [25]. Other domains include ketoreductases
(KR) which catalyze hydroxy group formation, dehydratases (DH)
which form double bonds after water elimination, enoyl reductases
(ER)which catalyzes reduction reaction of the double bonds andmethyl
transferases (MT) which introduce methyl groups and branching
in the carbon backbone. A phosphopantetheinyl transferase (PPT)
encoded by a sfp gene is essential for the activation of the ACP domains
[26,27]. The arrangement and the order of the catalytic domains within
PKS inﬂuence PKs biosynthesis leading to a remarkable diversity in
the PKs production. The PKS enzymes can be broadly categorized into
three types, depending on the architecture of catalytic domains [28].
Type I PKS enzymes contain modules organized in multiple catalytic
domains within a single protein that carry out decarboxylation and
condensation steps to generate PKs from the starter unit malonyl-CoA
[11]. In the type II and type III PKS enzymes, catalytic domains
are found in separate proteins [28]. A large group of bacterial PKs
are produced by modular PKS I enzymes with iterative KS, ACP and
modiﬁcation domains. These type I PKS mostly lack AT domains within
the clusters, malonyl-CoA is transfered by acyl transferases acting in
trans [29]. A large number of PKS is often found in association with
NRPS as hybrid enzymes type I PKS-NRPS [30].
Metabolites produced by Bacillus amyloliquefaciens and Bacillus
subtilis represent a substantial part of the diversity of LPs and PKs
from the genus Bacillus [31,32]. The majority of the plant growth pro-
moting and biocontrol agents commercially available are produced by
these two species [4]. They produce three types of polyene PKs compris-
ing bacillaene, difﬁcidin and macrolactin [26,32]. B. amyloliquefaciens
FZB42 contains a genome size of 3918 kb, of which nearly 200 kb are
devoted to the production of polyketides. These three giant PKs gene
clusterswere assigned unambiguously by amutagenesis study, utilizing
MALDI-TOF MS and LC-ESI MS techniques [26]. In the genus
Paenibacillus two PKs have beendescribed so far. The underlying genetic
cluster remains to be unambiguously identiﬁed in the case of
paenimacrolidin [33], while for the recently described paenilamicins
from Paenibacillus larvae also the responsible gene clusters have
been reported [34]. In the following we describe the ﬁve known types
of PKS from Bacillus and Paenibacillus in more detail.
1.1.1. Bacillaene
Bacillaene was ﬁrst reported in the culture medium of B. subtilis
strains 3610, and 55422 [35,36]. It has a linear structure comprising a
conjugated hexaene (Fig. 2A) [35,36]. The biosynthesis of bacillaene
has been described in B. amyloliquefaciens FZB42 and is encoded by a
hybrid type I PKS-NRPS gene cluster called bae [26] (Fig. 1A). This
cluster shares architectural characteristics with pksX of B. subtilis strain
168, presumably also encoding bacillaene [26]. The bae gene cluster
contains ﬁve long open reading frames (ORFs) including baeJ, baeL,
baeM, baeN and baeR [26]. The ﬁrst and the second adenylation domains
of baeJ are responsible for the incorporation of α-hydroxy-isocaproic
acid and glycine, respectively. The third adenylation domain of baeN is
involved in the incorporation of alanine [37]. Modules 4, 8 and 14
are splitted between adjacent genes (Fig. 1A). Three short ORFs found
upstream of baeJ are baeC, baeD, baeE, encode for the three discrete AT
domains that load malonyl-CoA [37]. Bacillaene and dihydrobacillaene
are structural variants represented in this group of PKs [27,36]
(Fig. 2A). Cell viable assays revealed that bacillaene selectively
inhibits protein biosynthesis in prokaryotes, but not in eukaryotes,
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Fig. 1. Architectures of type I polyketide synthases (PKS) showing similarities and dissimilarities in known and predicted PKs. Iterative domains: ACP, acyl carrier protein; PCP, peptidyl
carrier protein; A, adenylation; KS, ketosynthase; DH, dehydratase; MT, methyl transferase; KR, ketoreductase; TE, thioesterase. Further details of domains are described in Table 1.
Modules and recruited amino acids indicated below, gene names indicated above each illustration. (A) Gene clusters of the three types of well-known PKS from B. amyloliquefaciens
FZB42: (a) difﬁcidin, (b) macrolactin, (c) bacillaene. Modular regions of predicted PKS: (a) bacillaene variant from P. pini 16418; number and order of the domains differ from B.
amyloliquefaciens FZB42 bacillaene, (b) novel PKS from P. polymyxa E681; an adenylation domain speciﬁes glycine, (c) paenimacrolidine like PKS from P. durus DSM 1735, (d) novel
PKS form Brevibacillus brevis NBRC 100599; adenylation domains specify ala and ser, also contains themethylation domains- oMT and nMT. These predicted PKSmachinery in Paenibacillus
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their environment [35].
1.1.2. Difﬁcidin
Difﬁcidin is known to be produced by B. amyloliquefaciens strains
ATCC 39320 and ATCC 39374 (originally classiﬁed as B. subtilis in
the original paper [38]), and is a highly unsaturated macrocyclic poly-
ene comprising a 22 member carbon skeleton with a phosphate group
rarely found in secondarymetabolites. Oxydifﬁcidin, a structural variant
of difﬁcidin has an additional hydroxyl group incorporated at position
5 [38] (Fig. 2A). Difﬁcidin is encoded by the gene cluster dif with
14 open reading frames from difA to difN and difY (Fig. 1A). Difﬁcidin
and oxydifﬁcidin biosynthesis deviates from the colinearity rule as a
number of KR, DH and ER domains are absent within the gene cluster.
So module 3 lacks the KR domain, module 4 and 5 two DH domains
and modules 2 and 8 two ER domains, but these domains are found
acting in trans. The contribution of the genes difJ and difK are unclear
and their potential activities are not seen in the ﬁnal product [26].
Difﬁcidin shows antagonistic activity against broad range of bacteria
[39]. Difﬁcidin has been shown to be active against the phytopathogen
Erwinia amylovora causing ﬁre blight [31]. In Escherichia coli it
has been demonstrated that difﬁcidin is responsible for inhibiting pro-
tein biosynthesis [40].1.1.3. Macrolactin
Macrolactins have been isolated from B. amyloliquefaciens FZB42,
the soil bacterium Bacillus sp. AH159-1 and from marine Bacillus,
Actinomadura and uncharacterized species [41,42]. Most macrolactines
are consisting of a 24membered lactone ring with three dienemoieties
in the carbon backbone (Fig. 2A). The cyclic macrolactins are encoded
in B. amyloliquefaciens FZB42 by the gene cluster mln, containing
nine operons including mlnA-I [42] (Fig. 1A). The cluster contains 11
KS domains with malonate and acetate as the only used building
units. Unlike in the bacillaene gene cluster, only one trans AT domain
is found upstream of the mlnA gene. Similar to the dif gene cluster
organization, mln shows an unusual splitting of the modules. Module
2 is splitted between mlnB and mlnC and a similar organization is
seen for modules 5, 7, 8 and 10. A comparison of the order of the
catalytic domains has shown that module 2 lacks the ER domain while
modules 7 and 10 lack two DH domains. Like in dif, the activity of
the missing domains can be accomplished by domains located in trans
[42].
As the other Bacillus polyketides, macrolactins show antibacterial
activity and might have the potential to be used in medical application
[42]. In in vitro assays, they have also been shown to inhibit the
proliferation of murine melanoma cancer cells and the replication
of mammalian Herpes simplex virus and HIV in lymphoblast cells [43].
AB
Fig. 2. Chemical structures of polyketides of Bacillus and Paenibacillus. (A) Polyketides from B. amyloliquefaciens FZB42 (a, b, c) and Bacillus sp. AH159-1 (c): (a) difﬁcidins, (b) bacillaenes
and (c)macrolactins. Stereochemistry not shown. (B) Polyketides from Paenibacillus: (a) Paenimacrolidin from Paenibacillus sp. F6-B70. Stereochemistry unknown. (b) Paenilamicin from
P. larvae DSM25430.
195G. Aleti et al. / Computational and Structural Biotechnology Journal 13 (2015) 192–203
pmxA pmxB
pmxC
ExmpDxmp
leu thr dab dab thr dab dabthr dab dab
m6 m7 m8 m9 m10 m1 m2 m3 m4 m5
thr
m1 m2
tyr
m3
val thr
m4
asn
m5
ala
m6
fus
 C   A   T   E   C   A   T   E   C   A   T   E    C   A   T   E    C   A   T   E    C   A   T    C  
m1
val
m2
dab
m3
gly
m4
ser
m5
phe
m6
ser
m7
dab
m8
dab
m9
phe
m10
glu
m11
val
m12
ile
m13
ala
tridA tridB
MCT   
m1
ser
m2
orn
m3
phe
m4
val
m5
phe
m6
phe
m7
glu
predicted heptapeptide
A
B
polymyxin
fusaricidin
tridecaptinA
(a)
(b)
(c)
(a)
CAL   T   KS   T   AMT   MCT   
A   T   E   C   A   T   C   A   T   C   A   T   C  C   A   T   C   A   T   C   A   T   E   C   A   T   C   A   T   C    A   T   TE   
 C   A   T   C   A   T   E   C   A   T   C   A   T   C   A   T   E   C   A   T   TE    
 A   T    C   A   T   E    C   A   T    C   A   T   C         A   T   C   A   T   E   C   A   T   TE 
CAL   T   KS   T   AMT   T   AMT   C   T   C   A   T   E  C   A   T   E   C   A   T   E   C   A   T   E   C   A   T   C   A   T   C   A   T   C 
  C   T   C    A   T   C A   T   E   C   A   T   TE       A   T   E   C   A   T   E   C   A   T   C   A   T   C   
m1 m2 m3 m4 m5 m6 m7
asn
mycAfenF mycB mycC
tyr asn gln pro ser ser
mycosubtilin (iturin family)
(b)
Fig. 3.Organization of the non-ribosomal peptide synthetases (NRPS) encoding lipopeptides in Paenibacillus and Bacillus. Iterative domains: A, adenylation; T, thiolation; E, epimerization;
MCT,malonyl-CoA transacylase; ACL, acyl-coA ligase; AMT, aminotransferase; dab, 2,4-diaminobutyric acid; orn, ornithine; KS, keto synthetase; TE, thioesterase. Further details of domains
are described in Table 1. Modules and recruited amino acids indicated below, gene names indicated above each illustration. (A) Organization of the known NRPS (a) polymyxin A in
P. polymyxa E681, (b) fusaricidin in P. polymyxa E681 and (c) tridecaptin A in P. terrae NRRL B-30644. (B) Organization of the predicted novel NRPS encoding (a) a heptapeptide in
P. polymyxa E681;modular architecture is similar to the known Iturin but predicted amino acid composition is completely different and (b) organization of the knownmycosubtilin operon
[69], an iturin member from B. subtilis for comparison.
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Paenimacrolidin is a highly unstable macrocyclic lactone isolated
from Paenibacillus sp. F6-B70 and comprises a 22 membered lactone
ring with a triene in the carbon backbone [33] (Fig. 2B). Three out of
four partial genes of the paenimacrolidin synthase showed high similar-
ity to difﬁcidin synthase of B. amyloliquefaciens and the structure of
paenimacrolidin has similarities with difﬁcidin, implying potential
similarities in the biosynthesis and underlying genetic structures
(Fig. 2A). Paenimacrolidin also exhibits antimicrobial activity against
Staphylococcuswith potential in clinical applications [3].1.1.5. Paenilamicin
Paenilamicins with antibacterial and antifungal activity have been
isolated from P. larvae DSM25430, a honey bee pathogen [44]. Despite
their activities these compounds do not seem to be involved in host
killing, but rather in niche competition [34]. Based on gene activation
studies the biosynthesis of paenilamicins has been assigned to the
pam gene cluster (a complex NRPS/PKS hybrid gene cluster), and the
structure (Fig. 2B) was elucidated using HPLC–ESI-MS, GC–MS, and
NMR spectroscopy [34]. Different variants of paenilamicins are found
due to variation in the ﬁrst (lysine or arginine) and fourth (lysine or
ornithine) recruited amino acid, but synthesis is performed by the
very same enzyme complex encoded by pam. The non-ribosomal
peptide synthetases 2, 3, 5, 6 and 7 encode alanine, N-methyl-
diaminopropionic acid (mDap), serine, mDap and glycine, respectivly.
Both PKS 1 and 2 mediate the formation of 2,3,5-trihydroxy pentanoicFig. 4. Chemical structures of lipopeptides from Bacillus and Paenibacillus. (A) Lipopeptides fro
(c) plipastatin (a fengycin member) and (d) kurstakin from B. thuringiensis kurstaki HD-1. (B)
C from P. polymyxa E681, (c) paenibacterin from Paenibacillus sp. OSY-SE (d) tridecaptin fromacid, which is then condensed to alanine. Finally, termination is
achieved by nucleophilic cleavage by spermidine without involving
thioesterase [34].
1.2. Bacillus and Paenibacillus lipopeptides
Lipopeptides from Bacillus and Paenibacillus have been described in
a number of recent reviews [4,6,7,32,45,46]. These LPs are synthesized
by non-ribosomal peptide synthetases (NRPS) [47]. NRPS comprise
organized modules, each module containing catalytic domains: the
adenylation (A) domain responsible for selection and monomer activa-
tion, the thiolation (T) domain for transfer of the adenylated monomer
to a NRPS bound PPT, the condensation domain (C) for peptide bond
formation and the thioesterase (TE) domain for release of the peptide
monomer fromNRPS. Also modiﬁcation domains such as epimerization
(E) domain catalyzing the isomerization of L- into D-amino acid mono-
mers and methyl transferase (MT) are found. The starter condensation
domain within the ﬁrst module catalyzes the attachment of a fatty
acid chain to the amino acid activated by the ﬁrst adenylation domain
[47] (Fig. 3). The gene clusters of the Bacillus LPs encoding the surfactin,
fengycin, iturin and kurstakin families have been described and summa-
rized in detail in a number of reviews [4,45,46].
Structurally, LPs consist of short oligopeptides (6–13 AA) with at-
tached linear or branched fatty acids. For Bacillus and Paenibacillus linear
and cyclic structures have been described (Fig. 4 shows examples of the
variation) [7]. A large fraction of the Paenibacillus LPs are cyclic cationic
LPs which contain the non-proteogenic amino acid 2,4-diaminobutyricm B. amyloliquefaciens FZB42 (a,b,c): (a) surfactin, (b) bacillomycin (an iturin member),
Lipopeptides from Paenibacillus: (a) polymyxin A from P. polymyxa E681, (b) fusaricidin
P. terrae NRRL B-30644.
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197G. Aleti et al. / Computational and Structural Biotechnology Journal 13 (2015) 192–203
198 G. Aleti et al. / Computational and Structural Biotechnology Journal 13 (2015) 192–203acid (dab) contributing to the overall positive charge of the cationic
lipopeptides. The polymyxins, octapeptins and polypeptins belong
to this group enriched in dab (for review see [7]). The cationic
lipopeptides have been reported as strong antibacterial agents
against gram-negative bacteria and their mode of action is through
permeabilization and disruption of the cell membrane [48,49].
Besides their clinical use as bactericidal agents, they have been
shown to be active against plant pathogenic Erwinia amylovora and
Pectobacterium carotovorum. [50]. The gene cluster responsible for
synthesizing polymyxin synthetase has been described in plant
growth promoting rhizobacteria such as P. polymyxa E681. The
cluster encompasses ﬁve genes, of which pmxA, pmxB and pmxE
encode the polymyxin synthetase, whereas pmxD and pmxC are in-
volved in polymyxin transport [51] (Fig. 3A). Based on the amino acid
substitutions at the positions 3, 6, 7 and 10, polymyxins are known to
have variants (Fig. 4B). Octapeptins contain eight monomers and ap-
pear to be truncated polymyxins with cyclic heptapeptide structures
in common. Like polymyxins they exhibit antibacterial activity against
both gram-positive and gram-negative bacteria by acting on the mem-
branes and are found in Paenibacillus spp. [52].
Polypeptins and pelgipeptins are cyclic nonapeptides isolated from
P. ehimensis B7 and P. elgii B69, respectively. They are active against
gram-positive and gram-negative bacteria, but also show antifungal
activity against Fusarium graminearum and Rhizoctonia solani [53,54].
The gene cluster encoding pelgipeptin has been recently characterized
in P.elgii B69 [55]. Other cyclic cationic LPs include gavaserin and
paenibacterins. Gavaserin is isolated from P. polymyxa and speculated
to contain a cyclic octapeptide structure [56]. Nevertheless, no struc-
tural data are available. Paenibacterins are known from Paenibacillus
sp. OSY-SE and contain a tridecapeptide backbone (Fig. 4B). As the
other cationic polypeptides they are active against gram-positive and
gram-negative bacteria [57].
Cyclic noncationic lipopeptides from Paenibacillus comprise
fusaricidins containing cyclic hexapeptide structure (Fig. 4B). They
have been reported to exhibit strong antagonistic activity against
Fusarium oxysporum [58]and induction of systemic resistance in red
pepper plants against Phytophthora [59]. In addition, also a group of
linear cationic LPs with different numbers of amino acids produced by
Paenibacillus has been described. They include tridecaptins, with strong
antimicrobial activity against gram-negative bacteria [60] (Fig. 4B).
The gene cluster coding for tridecaptinAα has been recently character-
ized from P. terrae NRRL B-30644 [61] (Fig. 3A). Cerexins are linear
decapeptides, isolated from B. cereus, which display strong antimi-
crobial activity against gram-positive bacteria [62].
Most prominently, B. amyloliquefaciens and B. subtilis encompass
gene clusters coding for cyclic LPs including surfactin, iturin, fengycin
and kurstakin (46,63) (Fig. 4A). Several variants that differ in few
amino acids have been reportedwithin each family except for kurstakin.
The LPs contain regularly variation in the fatty acid chain length and
have linear, iso or aniso structural variations.
All surfactins contain cyclic heptapeptide structure, but differ in
amino acid composition [64]. Known variants such as pumilacidin,
lychenisin and surfactin represent this group and are remarkably con-
ﬁned to speciﬁc taxonomic groups [4]. Surfactins are vital for bioﬁm for-
mation and root colonization, but also exhibit awide range of hemolytic,
antimicrobial and antiviral activities, while fungicide activity has not
been reported [65–68]. Surfactins are amphiphilic compounds, whose
mode of activity seems mainly through membrane permeabilization
and disruption [66].
All members of the iturin family have a cyclic heptapeptide struc-
ture, but differ from surfactins with distinct amino acid composition
and cyclic closure of the lipopeptide structure by a beta-amino group
of the fatty acid. Variants named bacillomycins, mycosubtilins, iturins
and marihysins are noted [4,7,46]. They are mainly known for strong
antifungal activity against several fungi [69–71]. Unlike surfactins
their antibacterial activity is limited [72].Fengycins and plipastatins are decapeptides which form a lactone
ring structure between the C-terminus and a tyrosine at position
three. They show remarkable antagonistic activity against ﬁlamentous
fungi. The three LPs surfactin, iturin and fengycin may also act synergis-
tically, enhancing their activities [73,74].
Kurstakins are another family of LPs isolated from B. thuringiensis
strains and have been identiﬁed as phylogenetic markers for the
species [75]. Kurstakins contain a lactone bond between Ser4 and
the C-terminus of Gln7 and consequently form a cyclic tetrapeptide
with a tetrapeptide side chain. They exhibit limited antifungal activi-
ty [63,75].
1.3. Genome mining tools for novel NRPS and PKS prediction
In order to discover novel secondary metabolites, several bioinfor-
matics tools are available to perform genome mining. Some of the
web based tools such as antiSMASH [20,21], NP.searcher [76] and
NaPDoS [22] use hidden Markov models to identify NRPS and PKS in
bacterial genomes. A more detailed prediction of the clusters is also
possible through antiSMASH, which allows BLAST search on the pre-
dicted cluster to identify closest homologue in the database. antiSMASH
allows the analysis of fragmented genomes and metagenomes making
it a powerful prediction tool. Predicted peptides can be queried on
NORINE database [77] containing more than 1000 non-ribosomal pep-
tides to ﬁnd similar structures [78]. Another useful prediction tool is
the NRPS/PKS substrate predictor [23], which mainly focuses on the
speciﬁcity of A domains (from NRPS) and AT domains (from PKS),
which is useful to narrow the ambiguity of A domains speciﬁcity that
occur in other prediction tools.
1.4. Prediction of lipopeptides and polyketides in published genome sets
In the following we evaluate the potential of type I PKs and LPs
production based on genome mining and analysis, and show a clear
potential for the discovery of several undiscovered variants and differ-
ent structures. The next generation sequencing revolution of the last
years have resulted and will result in a fast growing number of
sequencedbacterial genomes andmetagenomes. To evaluate the poten-
tial chemical space encoded in these genomes, the genomemining tools
described above can facilitate the prediction of secondary metabolites,
especially type I PKs and LPs. The cumbersome task, especially of various
unstable PKs, to isolate and elucidate structures by NMR methods
requiring milligram amounts can be pipelined by predicting the poten-
tial of novelty, also assisted by developments inmass spectrometry [79].
A limitation in prediction of PKs is that the colinearity rule common for
LPs does not always apply. However, based on the predicted modular
architecture and the number of core domains, it is still possible to
predict the types of PKs and their variants as we show for Bacillales in
the following (see Table 1 and Supplemental Table for an overview). A
total of 160 published genomes the Bacillales were analyzed, of which
91 genomes contained metabolic clusters encoding LPs, type I PKs or
both (57%). Intriguingly, a clear higher percentage, 85% of the 40
isolates, from rhizosphere and endophytes contained at least one of
these metabolic clusters (Supplemental Table). However, the origin of
almost a third of the isolates is unclear, making it difﬁcult to foresee, if
the higher incidence of these secondary metabolites in plant associated
environments will also be seenwhenmore genomeswill be sequenced.
A trend can be also seen phylogenetically with certain Bacillus spp. and
Paenibacillus spp. as the taxa with the highest numbers of both type I
PKs and LPs (Supplemental Fig.). How far also this observation just
reﬂects a higher density of available genomes in these taxa than e.g. in
Salinibacillus spp. remains to be seen.
Genomemining revealed the potential for known and novel LPs and
PKs. Based on the prediction of the general architecture, undescribed,
novel clusters can be identiﬁed (Supplemental Table, Table 1). Predic-
tion of recruited substrates allows also the prediction of novel variants
Table 1
Predicted lipopeptides and type I polyketides from selected members of Bacillales.
GenBank ID Organism Lipopeptide* Type I polyketide*
CP000154.1 Paenibacillus
polymyxa E681
Polymyxin A, structure and biosynthetic gene cluster conﬁrmed [SKChoi 2009,
Catch JR 1949]
L-dab-L-thr-D-dab-L-dab-L-dab-D-leu-L-thr-L-dab-L-dab-L-thr
Fusaricidin C, structure and biosynthetic gene cluster conﬁrmed
[Soo-Keun Choi 2008]
L-thr-D-val-L-tyr-D-thr-D-asn-D-ala
Predicted tridecaptin variant
D-val-D-dab-D-gly-D-ser-D-phe-L-ser-L-dab-D-dab-L-phe-L-glu-L-val-D-ile-L-val
Predicted unknown heptapeptide
(mal) + (pk) + D-ser-D-orn-D-phe-D-val-L-phe-L-phe-L-glu
47% identity to bacillomycin of B. amyloliquefaciens FZB42
Novel polyketide
gly (DH = 5, KS = 12, KR = 9, cMT = 2,
ACP = 14); 43% identity to known bacillaene of
B. amyloliquefaciens FZB42
ARIL00000000.1 Paenibacillus
polymyxa
SQR-21
Polymyxin A variant
L-dab-L-thr-D-dab-L-dab-L-dab-D-leu-L-leu-L-dab-L-dab-L-thr
Fusaricidin C (peptide sequence is similar to E681); 93%identity to
fusaricidin of P. polymyxa E681
Predicted tridecaptin variant, peptide sequence is similar to P. polymyxa
E681
Predicted unknown heptapeptide, peptide sequence similar to P. polymyxa
E681
Predicted decapeptide (maybe a truncated tridecaptin)
D-gly-D-dab-D-gly-D-ser-D-phe-L-ser-L-dab-D-dab-L-ile-L-glu
Novel polyketide (same as above) -
modular architecture is similar to P.
polymyxa E681. 43% identity to
bacillaene of B. amyloliquefaciens
FZB42
ARIL00000000.1 Paenibacillus
massiliensis DSM
16942
Novel fusaricidin variant L-thr-D-val-L-ile-D-ser-D-asn-L-ala; 49% identity to
fusaricidin of P.polymyxa E681.
No clusters found
CP006941.1 Paenibacillus
polymyxa CR1
Predicted heptapeptide variant (pk-nrp) + (thr-ser-ala) + (phe-gln-glu)
48% identity to bacillomycin of B. amyloliquefaciens FZB42
Incomplete PKS predicted
CP003235.1 Paenibacillus
mucilaginosus
3016
Predicted heptapeptide variant
phe + (orn-val-ile-phe-nrp-phe)
44% identity to bacillomycin of B. amyloliquefaciens FZB42
Incomplete PKS predicted
CP009288.1 Paenibacillus
durus DSM 1735
Incomplete NRPS predicted Paenimacrolidine
(KS = 9, DH = 6, cMT = 2, KR = 6,
ER = 1, ACP = 14) 40% identity to
known difﬁcidin of B.
amyloliquefaciens FZB42
BAVZ00000000.1 Paenibacillus pini
JCM 16418
Incomplete NRPS predicted Bacillaene variant, gly; ala (KS = 14,
DH = 8; KR = 8, cMT = 2, ACP = 16);
also the order of domains differ;
share 56% identity to bacillaene of B.
amyloliquifaciens FZB42
ANAT00000000.1 Paenibacillus
lentimorbus
NRRL
B-30488
Bacillomycin D, surfactin, plipastatin; similar to B. amyloliquefaciens
FZB42
Bacillaene, macrolactin, difﬁcidin;
similar to B. amyloliquefaceins
FZB42
AULE00000000.1 Paenibacillus
taiwanensis DSM
18679
Paenibacterin variant
(orn-val-thr-orn) + (tyr-orn-ser-ile-pro) + (pro) + (ile-ile); 69% identity
with known paenibacterin of Paenibacillus sp. OSY-SE
Incomplete PKS predicted
ARMT00000000.1 Paenibacillus
fonticola DSM
21315
Unknown heptapeptide-architecture similar to Iturin family
(mal) + (pk-gly) + (orn-glu) + (lys-tyr) + (ile-val); 36% identity with
known Bacillomycin of B. amyloliquefaciens FZB42
Incomplete PKS predicted
CP003355.1 Paenibacillus
larvae DSM
25430
IturinA Paenilamicins: A1, B1, A2, B2, -a
complex NRPS/PKS hybrid lys/arg,
ala, mdap, lys/orn, ser, mdap, gly
(KS = 4, KR = 4, nMT = 2, ACP = 4)
CP003763.1 Bacillus
thuringiensis HD-
789
Kurstakin, structure conﬁrmed [Hathout et al. 2000]
D-thr-L-gly-L-ala-L-ser-L-his-D-gln-L-gln
No clusters found
CP004069.1 Bacillus
thuringiensis
serovar kurstaki
HD73
Kurstakin variant
D-thr-L-ser-L-ala-L-ser-L-leu-D-nrp-L-gln
99% identity to known kurstakin of Bacillus thuringiensis serovar kurstaki
HD-1
No clusters found
CP000560.1 Bacillus
amyloliquefaciens
FZB42
SurfactinA [Peypoux F 1994, Koumoutsi A 2004]
L-glu-L-leu-D-leu-L-val-L-asp-D-leu-L-leu
Plipastatin B [Nishikiori 1986, Koumoutsi A 2004]
L-glu-D-orn-L-tyr-D-thr-L-glu-D-val-L-pro-L-gln-D-tyr-L-ile
Bacillomycin D [Peypoux F 1984, Koumoutsi A 2004]
L-asn-D-tyr-D-asn-L-pro-L-glu-D-ser-L-thr
Bacillaene gly; ala (KS = 14, DH = 8,
KR = 9, cMT = 2, ACP = 14)
Difﬁcidin (KS = 14; DH = 9, KR = 10,
cMT = 3, ER = 1, ACP = 19)
Macrolactin (KS = 11, DH = 5,
KR = 11, ACP = 15)
[Stein, 2005; Chen et al., 2006]
JOKF00000000.1 Bacillus
amyloliquefaciens
plantarum W2
SurfactinA-similar to FZB42, Plipastatin B (similar to FZB42 but Glu
instead of Gln)
Macrolactin variant (KS = 11, DH = 3,
KR = 11, ACP = 15); 97% identity
with known macrolactin of B.
amyloliquefaciens FZB42
Difﬁcidin variant (KS = 14, DH = 9,
KR = 10, CMT = 3, ER = 0, ACP = 19);
98% identity with know difﬁcidin of
(continued on next page)
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Table 1 (continued)
GenBank ID Organism Lipopeptide* Type I polyketide*
B. amyloliquefaciens FZB42
Bacillaene-similar to FZB42; 98%
identity to bacillaene of B.
amyloliquefaciens FZB42
NC_014639.1 Bacillus
atrophaeus 1942
SurfactinC
L-glu-L-leu-D-leu-L-val-L-asp-D-leu-L-ile; 78% identity to B.
amyloliquefaciens FZB42
Plipastatin B; mycosubtilin; similar to FZB42
Bacillaene variant, similar to FZB42
in terms of speciﬁcity of A domains
but (KS = 16, DH = 7, KR = 9, cMT = 2,
ACP = 16); 64% identity to B.
amyloliquefaciens FZB42
CM000488.1 Bacillus subtilis
NCIB 3610
SurfactinA; plipastatin B; similar to FZB42 bacillaene similar to FZB42
A domains speciﬁcity gly, nrp
(KS = 15, DH = 8, KR = 9, cMT = 2,
ACP = 17), 64% identity to known
bacillaene of B. amyloliquefaciens
FZB42
AP008955.1 Brevibacillus
brevis NBRC
100599
Incomplete NRPS predicted Novel polyketide
(KS = 14,cMT = 3, oMT = 1, nMT = 1,
KR = 8, ACP = 20), A domain
speciﬁcity ala, ser; 38% identity to
difﬁcidin of B. amyloliquefaciens
FZB42
AEWH00000000.1 Ornithinibacillus
scapharcae TW25
Incomplete NRPS predicted Macrolactin like polyketide
44% identity to B.
amyloliquefaciens FZB42 (KS = 13, DH= 4, KR = 8,
ACP = 16)
Bacillaene, similar to B.
amyloliquefaciens FZB42
APIS00000000.1 Salinibacillus
aidingensis MSP4
Surfactin, plipastatin B; similar to B. amyloliquefaciens FZB42 Macrolactin like polyketide (KS = 12, DH = 5,
KR = 6, ACP = 14) 45% idenity to bacillaene of
B. amyloliquefaciens FZB42
* Sequence prediction using antiSMASH, NaPDos and NRPS/PKS substrate predictor tools, peptides in bold are predicted novel peptides, monomers in both bold and underline differ from
describedmetabolites in that position (in case of polyketides they differ in number andmaybe in the order of domains); monomers in underline are known variants, previously described.
B. subtilis 3610 and B. amyloliquefaciens FZB42 are reported to produce similar bacillaene [Rebecca A. Butcher 2006, Chen 2009]. However, they differ in number of domains predicted.
Abbreviations: mal, malonyl-CoA; pk, polyketide; dab, 2,4-diaminobutyric acid; KS, ketosynthase; DH, dehydratase; MT, methyl transferase; KR, ketoreductase; orn, ornithine, nrp,
unassigned non ribosomal peptide, mdap, N-methyl-diaminopropionic acid, NRPS, non-ribosomal peptide synthetase, PKS, type 1 polyketide synthase.
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and substrate prediction cannot exclude additional secondarymodiﬁca-
tions. These clusters were not considered as “novel” in the current anal-
ysis, but indicated as similar to described clusters in Table 1 and in the
Supplemental Table. Especially in several Paenibacillus strains, we
found a high potential for novel undescribed PKs and LPs variants of
heptapeptides, nonapeptides, tridecaptins and decapeptides (truncated
tridecaptins). Besides this,many Paenibacillus strains encompass known
LPs such as polymyxins and fusaricidins and variants that differ in
monomer composition (Table 1). We found also a novel fusaricidin var-
iant in P.massiliensisDSM16942differing at the 4th position substituted
by serine, which is believed to be highly speciﬁc for allo-threonine.
Predicted heptapeptides from Paenibacillus strains have a modular
architecture similar to iturin (Fig. 3B). Monomers of the peptide back-
bone in these heptapeptides are however completely different from
the known iturin members. The genes in the heptapeptide operon
of P. polymyxa E681 show up to 46% identity to bacillomycin D, an iturin
member of B. amyloliquefaciens FZB42. Therefore, we hypothesize that
these may belong to a novel class of iturins. Also, such heptapeptide
variants with different peptide composition were found in other
Paenibacillus strains such as P. polymyxa CR1, SC2, and Paenibacillus sp.
HGH0039, P. mucilaginosus 3016 and P. fonticola DSM 21315. More-
over, we found an undescribed nonapeptide and its variants in
P. mucilaginosus 3016, P. elgii B69 and P. terrae HPL-003. We discovered
tridecaptin variants in P. polymyxa strains including E681, SQR21 and
ATCC 842 (Table 1). In addition, we predicted decapeptides containing
ten monomers, but with similar composition to tridecaptins. These
seem to be truncated tridecaptins and therefore undescribed potential
LPs of the P. polymyxa strains SQR21, M1 and SC2. We also identiﬁed a
novel paenibacterin variant in P. taiwanensis DSM 18679 and P. alvei
DSM 29 with four different amino acids to described metabolites of
Paenibacillus sp. OSY-SE (Fig. 3B).The majority of the Bacillus species that harbor lipopeptide gene
clusters from the three families comprising surfactin, iturin and
fengycin are B. amyloliquefaciens, B. atrophaeus and B. subtilis. More-
over, LPs (surfactins and fengycins) are predicted for B. licheniformis,
B. mojavensis and B. pumilus with known metabolic potential but also
for strains so far not characterized for their potential and lesswell inves-
tigated species such as Salinibacillus aidingensis (Table 1, Supplemental
Table). The fourth family kurstakin is conﬁned to B. thuringiensis strains.
A kurstakin variant is found in B. thuringiensis serovar kurstaki HD73
with altered amino acid composition in position 2 and 5. The D and L
forms of the monomers in a lipopeptide can also be predicted depend-
ing on presence and absence of the epimerization domains [80]. For in-
stance, many B. subtilis encode plipastatin B, a member of fengycin
family. Although plipastatin B and fengycin B are fengycin members
and share identical monomers in the backbone, they differ in L-Tyr
and D-Tyr, respectively, as also the chirality in monomers can be
predicted with prediction tools. Altogether, it can be noted that the so
far collected genome information conﬁrms well known LPs for a num-
ber of Bacillus and Paenibacillus strains, but also shows a clear potential
to produce a number of novel lipopeptides, especially in the genus
Paenibacillus. A large number of strains from other genera of the
Bacillales seem to lack the potential to produce LPs and PKs type 1 (Sup-
plemental Table). However, it cannot be excluded that draft genomes
may hinder the prediction of LPs and PKs (discussed below) if larger
gaps within the published genomes exist.
For the deﬁned structure of the polyketide paenimacrolidin from
Paenibacillus sp. F6-B70, the biosynthetic gene cluster is not character-
ized. Based on partial 16S rRNA gene analysis of Paenibacillus sp. F6-B70
it has been shown to be closely related to P. elgii and P. ehimensis [33].
We predicted a novel polyketide gene cluster that is similar in P. durus
DSM1735, P. elgii and P. ehimensis (Fig. 1B). The partial paenimacrolidin
synthase genes from Paenibacillus sp. F6-B70, have high similarity
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paenimacrolidin using prediction tools, we speculate that a gene cluster
with similarity to the difﬁcidin cluster of B. amyloliquefaciens FZB42
may be responsible for the production of paenimacrolidin or a related
PKS in these species (Table 1).
A number of very likely novel PKs with gene cluster architecture
similar to bacillaene (Fig. 1B) are found in the P. polymyxa strains
E681, SQR21, in P. pini JCM 16418 and in Brevibacillus brevis NBRC
100599 (Table 1). Intriguingly, in P. polymyxa strains, only one
adenylation domain specifying glycine was found, instead of glycine
and alanine as described in the bacillaene producer B. amyloliquefaciens
(Table 1). PKS modules from P. polymyxa E681 shared up to 43%
nucleotide sequence identity with baeN of B. amyloliquefaciens. Also for
this polyketide, we identiﬁed variants that differ in number of the
catalytic domains KS, DH, cMT and KR. In other P. polymyxa strains
such as ATCC 842, M1 and SC2 a similar PKS cluster can be found with
oneDHdomain less (Supplemental Table). In P. pini, theﬁrst adenylation
domain speciﬁes glycine like in bacillaene, while the second adenylation
domain speciﬁes serine instead of alanine. In B. brevis, the ﬁrst
adenylation domain speciﬁes alanine and the second adenylation
domain speciﬁes serine. Besides it contains specialmethylation domains
such as oMT and nMT that are not found in other polyketide clusters,
clearly pointing to an uncharacterized PKs encoded in this genome
(Fig. 1B).
Regarding the PKs anticipated from Bacillus, several strains
contained well described clusters for bacillaene, macrolactin and
difﬁcidin synthesis. Surprisingly, we also found variants of those, which
have not been anticipated to date, even in strains of B. amyloliquefaciens
and B. subtilis (Table 1 and Supplemental Table). However, prediction
has to be careful here as it has been shown that small variation in the
domain structure does not result in the production of different
bacillaenes [31,36]. Generally, and not surprisingly B. amyloliquefaciens
and B. subtilis are noted as proliﬁc producers of PKs. Other Bacillus
spp. encompassing PKS are B. atrophaeus, B. mojavensis and Brevibacillus
brevis with clearly different PKs potential. In more detail, macrolactin
variants are found in B. amyloliquefaciens strains such as IT-45, DC-12,
UASWS BA1 and B1895 and B. amyloliquefaciens plantarum such
as UCMB 5036, W2 and AH159-1. Bacillaene variants are found in
B. atrophaeus, B. subtilis strains and B. mojavensis RRC 101. In
B. atrophaeus and B. mojavensis RRC 101 variants have similar amino
acids like in B. amyloliquefaciens FZB42 but differ in number of catalytic
domains. In B. subtilis strains, we found variation to bacillaene as the
second adenylation domain speciﬁes glutamine, but the number of
catalytic domains is identical to B. amyloliquefaciens FZB42. It has also to
be stated that not all metabolite clusters of these species are expressed
or even be functional as seen in B. subtilis 168 [81]. This lab strain
obviously does not require its secondary metabolites anymore, very
likely unlike its relatives living in plant association in nature.
We also performed genome mining on Bacillales genera growing in
other environments. Intriguingly, the majority of these non-plant
associated bacteria do not harbor LPS and PKS. On the contrary, a large
fraction of the plant-associated bacteria contained LPS and PKS (Supple-
mental Table, Supplemental Fig.) with both Bacillus and Paenibacillus
dominating the distribution. However, bacteria such as Ornithinibacillus
and Salinibacillus occuring in soil environments seem also to have
the capacity to produce macrolactin-like polyketides with higher
dissimilarity to the macrolactin of B. amyloliquefaciens FZB42.1.5. Conclusions and future perspectives
Bacillus and some related genera can be phylogenetically separated
into ten distinct groups based on 16S rRNA gene sequence information
[82,83]. It is intriguing that the LPS and PKS gene clusters seem to
be constrained to particular species or groups (Supplemental Fig.),
potentially indicating the ecological role for such gene clusters.BLAST results can be often misleading in the prediction of metabolic
capacity as part of the target gene cluster can share similarity within
and between different gene clusters. Therefore, it is crucial to examine
the whole architecture of a particular gene cluster to obtain precise
results. With an increasing availability of genome information due to
advanced and better affordable next generation sequencing, we antici-
pate that therewill be enormous increase in the deposition of sequences
in public databases derived from uncultured and less studied bacteria.
Such sequence wealth can be a rich source for novel secondary metab-
olite production and can be explored to ﬁnd novel gene clusters
encoding secondary metabolites. Our results suggest that a substantial
fraction of predicted LPs and PKs from the metabolomes of Bacillales
are uncharacterized and their functions with regards to plant associa-
tion still remains to be established and other so far neglected Bacillales
with no published genomic data still remain unexplored.
2. Materials and methods
2.1. Genome sequences
NCBI accession numbers for the whole genome sequences of both
characterized and uncharacterized group of isolates from selected
members of the Bacillales were extracted. (Table 1, Supplemental
Table). Contigs of draft genomeswere extracted and saved as a fastaﬁle.
2.2. Secondary metabolite gene cluster prediction and analysis tools
Threeweb based tools, antiSMASH,NaPDos, andNRPS/PKS substrate
predictor tools were used for secondary metabolite gene cluster predic-
tion and analysis. The architecture of the gene clusters were predicted
using the antiSMASH program [20,21]. The catalytic domains of the
predicted gene cluster are deduced using NaPDoS [22]. To analyze
adenylation domains of NRPS and AT domains of PKS, NRPS/PKS sub-
strate predictor [23] was used.
Firstly, Genbank accession numbers were given as input for
antiSMASH. For draft genomes, the extracted ﬁles were uploaded to
antiSMASH. The predicted secondary metabolite gene clusters from
antiSMASH consisted of NRPS, PKS, hybrid PKS/NRPS, siderophore,
bacteriocin and lantibiotics. The clusters responsible for biosynthesis
of LPs and PKs were analyzed. Further predicted monomers were
conﬁrmedusingNaPDos andNRPS/PKS substrate predictor. For accuracy,
predictions from the three tools were analyzed. Regarding polyketides,
the number of core catalytic domains KS, DH, KR, ACP and ER were
noted. Finally, both lipopeptide and polyketide encoding gene clusters
were subjected to BLAST to ﬁnd the closest homologue available in the
database.
2.3. Phylogenetic analysis of predicted LPs and type I PKs
The 16S rRNA gene sequences were downloaded from RDP [84].
These sequences were clustered at 97% identity using clustalW, and a
tree was plotted using neighbor joining algorithm within MEGA6 [85].
The phylogenetic distribution of predicted LPs and PKs from genome
mining is combined with the tree and visualized in iTOL2 [86].
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.csbj.2015.03.003.
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